Alkyl Amines Chemicals Ltd Q2 FY2023 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/9k037e3w7lcv1oshmncv0gvb.pdf

Key Takeaways


Demand Environment & End-Market Health

Yogesh Kothari: "Even though industries are not supposed to use, like the Pharma industry and all, apparently, some of them are using it, you know, which is to some extent affecting tonnages. But it is something which is not going to stop."

Revenue & Volume Dynamics

Kirat Patel: "At the last Con-Call, we had indicated that we look at a long term period for 10% to 15% growth, which we have more or less achieved in the last 10 years. However, this year I don't think we will be able to. We may be on the lower side of this estimate. And it looks bit of a struggle given the environment right now."

Margins & Cost Structure

Kirat Patel: "A couple of years ago, we had enjoyed a very wide increase in margins, and we are now back to the normal."

New Products & Capacity Expansion

Kirat Patel: "We would like to be among the top three producers in the world, you know."

Competitive & Market Dynamics

Kirat Patel: "Who decides the price? As we keep saying, the price is decided by the market, and the market is decided by the competition. So, it's very rare that, unless you are a monopoly, you will get the chance to decide this."

Guidance & Commitments

CommitmentSpecificsTimeline
First new product launchFirst product (not made from any amine) to start productionBy end December 2022
Remaining new products rolloutOne or two products every quarter or six monthsOver 18–24 months from Q3 FY23
Ethylamine expansion completionCurrent expansion finishedMay/June 2023
Kurkumbh aliphatic amines plantMechanical completion April; commissioning May end/June 2023; on schedule, within budgetMay/June 2023
Long-term volume growth CAGR10–15% (achieved over last 10 years); this year on the lower sideFY23 as a transition year; resumption when environment settles
New product revenue contributionFive/six products to add 20–25% of top line at full capacity (₹600–800 Cr sales potential)3–4 years from launch for full asset utilization
Minimum ROCE threshold20–25% across projects; higher for new products, lower acceptable for existingOngoing investment criterion
Margin defenseTrying to defend current normalized margins; market to settle to reasonable price/cost equationNo specific timeline; "very difficult to predict"

Key Metrics

MetricQ2 FY23
RevenueVolume more or less flat QoQ; top-line decline largely value-driven due to price drops
H1 FY23 top-line growth splitAbout one-third volume, about two-thirds price
Overall capacity utilizationBetween 70%–80%
Ethylamine expansion capacity addition100 tons per day, commissioning by May/June 2023
Aliphatic amines plant investmentAround ₹400 crores, commissioning May end/June 2023
New products planned capacity (excl. ethylamine)25,000 to 30,000 tons aggregating across five/six products
New products revenue potential (excl. ethylamine)₹600 to 800 crores at full capacity, 3–4 years out
New products contribution predictionAlmost 20–25% of top line going forward
Long-term volume growth guidance10% to 15% CAGR; current year likely on lower side, a struggle
Existing methylamine capacity~200 tons per day (Dahej ~150 tpd, Patalganga 50 tpd)
Existing ethylamine capacity75 tons per day (Kurkumbh 50 tpd, Patalganga 25 tpd)
Acetonitrile total capacity28,000 to 30,000 tons (Kurkumbh ~12,000 tons, Dahej 16,000–18,000 tons)
Indian acetonitrile market size~28,000 to 30,000 tons last year, may have had small degrowth
Return on capital employedBetween 20% and 25% over a 10-year or last 5-year period